Income Statement

CATALYST PHARMACEUTICALS, INC.

CPRX
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Revenue
588.99 491.73 398.20 214.20 140.83 119.07 102.31 0.50 0.00 0.00 0.00 0.00 - - -
Cost of Revenue
87.25 68.85 51.97 34.39 21.88 17.04 14.76 - - - - - - - -
Gross Profit
501.74 422.89 346.24 179.81 118.95 102.03 87.55 0.50 - - - - - - -
Operating Expenses
-25.42 -25.30 226.86 77.97 66.56 60.73 55.72 35.80 18.68 19.28 20.40 14.59 10.31 5.22 6.08
Research & Development
12.71 12.65 93.15 19.79 16.94 16.50 18.84 19.92 11.38 11.37 11.80 10.12 8.10 2.66 3.38
Selling, General & Administrative
193.75 177.74 133.71 58.18 49.63 44.23 36.88 15.88 7.30 7.91 8.60 4.47 2.21 2.56 2.70
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
295.28 232.50 119.38 101.84 52.39 41.30 31.82 -35.30 -18.68 -19.28 -20.40 -14.59 -10.31 -5.22 -6.08
Non-Operating Income
11.76 16.24 24.87 -2.88 -0.28 -0.59 -1.59 -1.29 -0.27 -1.21 -0.17 0.92 1.84 -1.14 0.31
Interest Income
- - - - - - - - - - - - 0.05 0.01 0.01
Interest Expense
- - - - - - - - - - - - - - -
Other Non-Op Income / Expense
25.74 21.14 7.70 2.88 0.28 0.59 1.59 1.29 0.45 0.32 0.10 0.08 - - -
Income Before Tax
283.52 216.26 94.51 104.72 52.67 41.89 33.41 -34.00 -18.41 -18.07 -20.23 -15.51 -12.15 -4.08 -6.39
Income Tax Expense
69.19 52.37 23.10 21.64 13.19 -33.09 1.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Controlling Interest
- - - - - - - - - - - - - - -
Net Income
214.33 163.89 71.41 83.08 39.48 74.98 31.88 -34.00 -18.41 -18.07 -20.23 -15.51 -12.15 -4.08 -6.39
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
295.28 232.50 119.38 101.84 52.39 41.30 31.82 -35.30 -18.68 -19.28 -20.40 -14.59 -10.29 -5.21 -6.04
Earnings Per Share (Basic)
1.75 1.38 0.67 0.80 0.38 0.72 0.31 - - - - - - - -
Diluted EPS
1.68 1.31 0.63 0.75 0.37 0.71 0.30 - - - - - - - -
Weighted Average Shares
122.29 118.46 106.28 103.37 103.38 103.51 102.94 - - - - - - - -
Diluted Weighted Avg Shares
127.26 124.94 113.75 111.38 107.80 106.24 106.02 - - - - - - - -
Comprehensive Income
214.26 163.94 71.40 83.25 39.30 75.00 31.91 -34.02 - - - - - - -